Medy-Tox Inc

XKRX:086900 (Korea (the Republic of))  
â‚© 135500.00 (0%) May 14
103.44
P/B:
1.94
Market Cap:
â‚© 912.09B ($ 673.51M)
Enterprise V:
â‚© 961.80B ($ 710.22M)
Volume:
16.51K
Avg Vol (2M):
48.77K
Volume:
16.51K
Avg Vol (2M):
48.77K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Medy-Tox Inc ( XKRX:086900 ) from 2009 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medy-Tox stock (XKRX:086900) PE ratio as of May 15 2024 is 103.44. More Details

Medy-Tox Inc (XKRX:086900) PE Ratio (TTM) Chart

To

Medy-Tox Inc (XKRX:086900) PE Ratio (TTM) Historical Data

Total 1264
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Medy-Tox PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-15 103.4 2024-03-08 111.1
2024-05-14 103.4 2024-03-07 112.6
2024-05-13 103.4 2024-03-06 116.4
2024-05-10 104.6 2024-03-05 117.4
2024-05-09 107.7 2024-03-04 116.5
2024-05-08 106.4 2024-02-29 120.6
2024-05-07 105.3 2024-02-28 122.4
2024-05-03 105.7 2024-02-27 121.4
2024-05-02 104.8 2024-02-26 122.2
2024-04-30 103.0 2024-02-23 140.5
2024-04-29 104.5 2024-02-22 141.4
2024-04-26 98.6 2024-02-21 142.5
2024-04-25 98.7 2024-02-20 143.1
2024-04-24 100.9 2024-02-19 143.3
2024-04-23 99.8 2024-02-16 145.0
2024-04-22 101.7 2024-02-15 144.1
2024-04-19 99.4 2024-02-14 141.6
2024-04-18 101.2 2024-02-13 143.4
2024-04-17 97.8 2024-02-08 141.4
2024-04-16 101.0 2024-02-07 143.4
2024-04-15 105.0 2024-02-06 143.7
2024-04-12 104.7 2024-02-05 141.8
2024-04-11 102.8 2024-02-02 147.9
2024-04-09 104.2 2024-02-01 145.3
2024-04-08 104.8 2024-01-31 147.2
2024-04-05 107.6 2024-01-30 152.7
2024-04-04 108.2 2024-01-29 149.6
2024-04-03 110.1 2024-01-26 153.1
2024-04-02 109.9 2024-01-25 153.8
2024-04-01 112.2 2024-01-24 155.0
2024-03-29 111.1 2024-01-23 156.9
2024-03-28 112.6 2024-01-22 155.7
2024-03-27 112.6 2024-01-19 158.4
2024-03-26 112.0 2024-01-18 164.5
2024-03-25 107.7 2024-01-17 168.7
2024-03-22 107.7 2024-01-16 173.3
2024-03-21 107.5 2024-01-15 178.2
2024-03-20 107.1 2024-01-12 179.8
2024-03-19 106.3 2024-01-11 183.2
2024-03-18 108.4 2024-01-10 180.5
2024-03-15 108.4 2024-01-09 182.4
2024-03-14 108.5 2024-01-08 181.3
2024-03-13 108.4 2024-01-05 182.8
2024-03-12 107.8 2024-01-04 184.3
2024-03-11 108.7 2024-01-03 188.2

Medy-Tox Inc (XKRX:086900) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.